• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    More On ASTM

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Vericel Corporation (ASTM)

    -NasdaqCM
    2.77 0.00(0.00%) Nov 24, 4:00PM EST
    Add to Portfolio
    Prev Close:2.77
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:4.88
    Beta:1.76
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:2.55 - 7.00
    Volume:0
    Avg Vol (3m):204,135
    Market Cap:65.77M
    P/E (ttm):N/A
    EPS (ttm):-3.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ASTM 0.00%65.77M
    BAXUp 2.18%39.17B
    CYTXUp 4.26%45.29M
    JNJUp 1.27%291.30B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aastrom Biosciences, Inc., a clinical-stage biotechnology company, focuses on the development of cell therapies for use in the treatment of severe chronic ischemic cardiovascular diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback